SCHEMBL20533663

SCHEMBL20533663

Cc1nn2c(N)cc(Cl)nc2c1Br

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.43
MAPT P10636 7/20 0.43
MEN1 O00255 5/20 0.43
ALDH1A1 P00352 5/20 0.43
L3MBTL1 Q9Y468 3/20 0.41
KDM4E B2RXH2 5/20 0.39
LMNA P02545 3/20 0.36
GAA P10253 1/20 0.36
NPC1 O15118 4/20 0.34
RAB9A P51151 4/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
GPR55 Q9Y2T6 1/20 0.34
HPGD P15428 3/20 0.33
NPSR1 Q6W5P4 2/20 0.33
STAT3 P40763 1/20 0.33
STAT1 P42224 1/20 0.33
CASP3 P42574 1/20 0.33
SENP8 Q96LD8 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP6 Q9GZR1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20533908 0.84 MAPT (0.45) KMT2AMAPTMEN1ALDH1A1L3MBTL1
SCHEMBL12888873 0.74 MAPT (0.56) KMT2AMAPTMEN1ALDH1A1L3MBTL1
SCHEMBL13317918 0.70 KDM4E (0.40) KMT2AMAPTMEN1ALDH1A1L3MBTL1
SCHEMBL11931303 0.70 CDK2 (0.56) KMT2AMAPTMEN1ALDH1A1KDM4E
SCHEMBL20448948 0.70 PI4KB (0.56) KMT2AMAPTMEN1ALDH1A1KDM4E
SCHEMBL8823005 0.69 KDM4E (0.49) KMT2AMAPTMEN1ALDH1A1L3MBTL1
SCHEMBL20528852 0.69 L3MBTL1 (0.44) KMT2AMAPTL3MBTL1LMNAGAA
SCHEMBL20534145 0.68 KDM4E (0.60) KMT2AMAPTMEN1ALDH1A1KDM4E
SCHEMBL23797868 0.67 TERT (0.40) KMT2AALDH1A1KDM4ELMNACYP1A2
SCHEMBL23460193 0.67 L3MBTL1 (0.45) KMT2AMAPTMEN1ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180298009-A1 Fused Pyrazole Derivatives As Kinase Inhibitors UCB BIOPHARMA SPRL (BE) 2018-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180298009-A1 Fused Pyrazole Derivatives As Kinase Inhibitors PI4KA, PI4K2B, PI4KB KMT2A 2326/4885MAPT 2367/4885MEN1 3280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.